Eli Lilly’s weight loss drug Zepbound shows promise as a sleep apnea treatment in late-stage trials
The pharmaceutical giant plans to present the trial data at an upcoming medical conference and submit them to the U.S.
Read MoreThe pharmaceutical giant plans to present the trial data at an upcoming medical conference and submit them to the U.S.
Read MoreThe review examined several drugs from Novo Nordisk, including Wegovy, Ozempic, Rybelsus, and Saxenda, but did not include Eli Lilly's
Read MoreWalgreens posted a steep net loss for the quarter as it recorded a hefty goodwill impairment charge related to its
Read MoreThe results are a sign that Altimmune can address an area of concern around weight loss drugs, which is that
Read MoreThe Viking study results add to the growing excitement around the biotech company and its potential in the budding weight
Read MoreApplying Nvidia AI chips to health care, whether it's biotechnology, chemicals, or drug discovery is going to be a big
Read MoreAmgen is testing a monthly injection that works differently and appears to help patients maintain their weight loss even after
Read MoreSome patients are willing to pay more for GLP-1 weight loss drugs like Wegovy than others — and it's strongly
Read MoreMedicare patients can soon get coverage for Novo Nordisk's Wegovy as long as it is prescribed to reduce their risk
Read More